Announce Date | 08/07/2025 |
EPS Normalized Actual | $0.25 (Beat by $0.04) |
EPS GAAP Actual | $0.25 (Beat by $0.04) |
Revenue Actual | $0B |
Revenue Surprise | Beat by $0M |
Announce Date | 12/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0.23391 |
EPS GAAP Estimate | $0.23391 |
Revenue Estimate | $0.114117308B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 0.93956 | 13.08 | 0.92212 | 0.95996 | 1 |
Dec 2026 | 0 | INF | 0 | 0 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | -0.26 | -0.26 | 0B | -INF% | -110.37M |
FQ1 2025 (Mar 2025) | 1.38 | 1.38 | 0.059824B | -73.86% | -48.74M |
FQ4 2024 (Dec 2024) | -0.41 | -0.41 | 0.100859B | 0.95% | -1.74M |
FQ3 2024 (Sep 2024) | -2.2 | -2.43748 | 0.107135B | 9.57% | 1.71M |
FQ2 2024 (Jun 2024) | 0.44 | 0.23488 | 0.108567B | 9.25% | 5.32M |
FQ1 2020 (Mar 2020) | 0 | 0 | 0.080438B | 100% | 80.44M |
FQ3 2020 (Sep 2020) | 0 | 0 | 0.062562B | 100% | 62.56M |
FQ1 2024 (Mar 2024) | 0.2 | -0.00417 | 0.10401B | 100% | 2.8M |
FQ4 Announce Date
12/30/2025 (Pre-Market)
Consensus EPS Estimates
0.23391
Consensus Revenue Estimates
0.114117308B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | 0.31063 | -- | 0.30134 | 0.31915 | 1 |
FQ3 2026 (Sep 2026) | 0.2615 | -- | 0.25684 | 0.27087 | 1 |
FQ2 2026 (Jun 2026) | 0.2526 | 202.93 | 0.2481 | 0.26165 | 1 |
FQ1 2026 (Mar 2026) | 0.29617 | -365.95 | 0.28732 | 0.30429 | 1 |
FQ4 2025 (Dec 2025) | 0.23391 | 275.28 | 0.22692 | 0.24033 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | 0.12B | -- | 0.12B | 0.13B | 4 |
FQ3 2026 (Sep 2026) | 0.12B | -- | 0.12B | 0.12B | 4 |
FQ2 2026 (Jun 2026) | 0.12B | -- | 0.12B | 0.12B | 5 |
FQ1 2026 (Mar 2026) | 0.11B | 47.81 | 0.11B | 0.12B | 4 |
FQ4 2025 (Dec 2025) | 0.11B | 11.62 | 0.11B | 0.12B | 6 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
4
EPS # of in-lines
2
Revenue # of Beats
5
Revenue # of Misses
3
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 0 | -0.26 | -0.26 | 100% |
FQ1 2025 (Mar 2025) | 0 | 1.38 | 1.38 | 100% |
FQ4 2024 (Dec 2024) | 0 | -0.41 | -0.41 | 100% |
FQ3 2024 (Sep 2024) | 0.23748 | -2.2 | -2.43748 | 110.79% |
FQ2 2024 (Jun 2024) | 0.20512 | 0.44 | 0.23488 | 53.38% |
FQ1 2020 (Mar 2020) | 0 | 0 | NAN% | |
FQ3 2020 (Sep 2020) | 0 | 0 | NAN% | |
FQ1 2024 (Mar 2024) | 0.20417 | 0.2 | -0.00417 | -2.08% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $0.11B | $0B | $-110.37M | -INF% |
FQ1 2025 (Mar 2025) | $0.11B | $0.06B | $-48.74M | -81.47% |
FQ4 2024 (Dec 2024) | $0.1B | $0.1B | $-1.74M | -1.73% |
FQ3 2024 (Sep 2024) | $0.11B | $0.11B | $1.71M | 1.6% |
FQ2 2024 (Jun 2024) | $0.1B | $0.11B | $5.32M | 4.9% |
FQ1 2020 (Mar 2020) | $0B | $0.08B | $80.44M | 100% |
FQ3 2020 (Sep 2020) | $0B | $0.06B | $62.56M | 100% |
FQ1 2024 (Mar 2024) | $0.1B | $0.1B | $2.8M | 2.69% |